Annual report pursuant to Section 13 and 15(d)

Schedule of Stock-based Compensation Expense (Details)

v3.24.1
Schedule of Stock-based Compensation Expense (Details) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total $ 2,371,214 $ 8,828,713
Research and Development Expense [Member]    
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total 363,956 2,895,653
General and Administrative Expense [Member]    
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total $ 2,007,258 $ 5,933,060